KEY POINTS
- mPharma investment Ghana backs expansion into Francophone markets.
- Funding supports an asset light pharmacy franchise model.
- The deal highlights rising health-tech investor confidence.
Growth Investment Partners (GIP) Ghana Ltd, a platform for small and medium sized businesses funded by British International Investment, has made a strategic investment in mPharma, a healthcare startup based in Accra and co-founded by Ghanaian entrepreneur Gregory Rockson.
The money is meant to help the company grow faster in the region and make its pharmaceutical supply chain model stronger.
The purchase would help mPharma’s QualityRx franchise model reach French speaking regions like Togo and Benin. This will help the company grow outside Anglophone West Africa. The deal didn’t say how much it cost, but it shows that investors are more interested in health-tech platforms that can develop their businesses and have a measurable social benefit.
mPharma investment Ghana drives regional expansion
The mPharma investment Ghana is likely to help the company grow its asset-light franchise network, which works with independent pharmacies instead than owning stores. Through proprietary software, mPharma standardizes pricing, manages inventory, and reduces stock-outs, addressing long-standing inefficiencies in Africa’s fragmented drug supply chains.
Within its existing network, the company says 72 percent of patients report lower medicine prices, while 96 percent experience fewer stock shortages. Its chronic care programs have also shown impact. Under the Diabetes Test & Treat initiative, about 80 percent of enrolled patients achieved optimal glycemic control within six months, according to company data.
Rockson said the new backing would allow mPharma to move faster in closing healthcare access gaps across the region, particularly in underserved urban and peri urban communities. GIP Ghana’s Chief Executive Officer, Jacob Kholi, said the firm was drawn to businesses capable of delivering both social and economic returns at scale.
mPharma investment Ghana signals investor confidence
Founded in 2013 by Rockson alongside Daniel Shoukimas and James Finucane, mPharma has built its reputation by managing inventory and pricing for small pharmacies while offering financing and supply chain support to hospitals and patients. The company works in a number of African markets and has made a name for itself as one of the best health-tech platforms on the continent.
According to Billionaires Africa, the alliance also makes it easier for mPharma to work with regional distributors like Ubipharm, GAPOB, and Laborex. This helps make sure that the company follows the rules and that logistics go more smoothly when it enters new markets. The deal shows that people are becoming more confident in Ghana’s startup scene and in companies that are based there that use technology to fill important gaps in healthcare.
